Regarding regulatory process; EPGL has nothing to do with FDA regulatory processes. EPGL is to earn revenues for its development of technologies regardless of regulatory requirements and in most cases, will be paid long before a particular product or device hits the market. EPGL is not responsible for costs of manufacturing, marketing or regulatory. As disclosures have mentioned, EPGL has more than one option for monetization of our valuable technologies.
http://www.epglmed.com
https://twitter.com/EPGLMed
$EPGL
$COO
$INTC
#smartcontactlens
#wearabletech
#consumerelectronics